The mission of the Survey Methods Core (SMC) facility is to assist Moffitt Cancer Center members with the design, implementation, and execution of research involving survey methods. Services provided by the SMC include consultations on research design, methods, and implementation, as well as the production and processing of scannable, web-based, and Computer Assisted Telephone Interviewing (CATI) surveys. Also offered are consultations about qualitative methods, including interviews, focus groups, and cognitive debriefing. The core has grown significantly since 2006. In addition to increasing and enhancing the range of services, the Core has added technical staff and expanded its physical space. The Core has more than doubled its space and now has four computer workstations in 300 square feet of space, as well as 300 square feet in a private CATI lab with four telephone interviewing stations. Currently there are three full-time positions and one part-time interviewer position. Since its inception, the SMC has implemented a working chargeback structure, increased its technical staff, and enhanced its menu of services. The Core's user base has been extended to include members from the Experimental Therapeutics and Molecular Oncology and Drug Discovery programs as well as those from the Health Outcomes and Behavior and Cancer Epidemiology. The Core requests CCSG Support of $83,457 which is 48% of its current operational budget. Over 84% of usage is by Moffitt members and peer-reviewed.

Public Health Relevance

Survey methods are vital tools in cancer prevention, detection, and control research and are increasingly useful in clinical investigations of new cancer therapies. The data collection process, particularly for large-scale studies and studies using multiple sites, can be time consuming;however, services provided by the SMC have streamlined the process.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
H. Lee Moffitt Cancer Center & Research Institute
United States
Zip Code
Tauro, Marilena; Shay, Gemma; Sansil, Samer S et al. (2017) Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth. Mol Cancer Ther 16:494-505
Davis, Stacy N; Christy, Shannon M; Chavarria, Enmanuel A et al. (2017) A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Cancer 123:1390-1400
Song, Jinming; Hussaini, Mohammad; Zhang, Hailing et al. (2017) Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis. Am J Clin Pathol 147:444-452
Strom, Tobin; Harrison, Louis B; Giuliano, Anna R et al. (2017) Tumour radiosensitivity is associated with immune activation in solid tumours. Eur J Cancer 84:304-314
Heit, Claire; Marshall, Stephanie; Singh, Surrendra et al. (2017) Catalase deletion promotes prediabetic phenotype in mice. Free Radic Biol Med 103:48-56
Eksioglu, E A; Chen, X; Heider, K-H et al. (2017) Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858. Leukemia 31:2172-2180
Kamath, Vidya P; Torres-Roca, Javier F; Eschrich, Steven A (2017) Integrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity. Int J Genomics 2017:6576840
Liu, Ying; Balagurunathan, Yoganand; Atwater, Thomas et al. (2017) Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules. Clin Cancer Res 23:1442-1449
Chen, Yi; Fisher, Kate J; Lloyd, Mark et al. (2017) Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins. Methods Mol Biol 1647:19-45
Extermann, Martine; Leeuwenburgh, Christiaan; Samiian, Laila et al. (2017) Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. J Geriatr Oncol 8:69-75

Showing the most recent 10 out of 1137 publications